Before he launched a venture-backed biotech startup, prior even to landing a research role in one of the world’s premier academic labs, Anindya Roy arrived in the U.S. with two suitcases and $2,000 in the bank. Read More
A Seattle biotech startup born from a Nobel laureate’s lab has landed $12.7 million and partnerships with pharmaceutical giants Pfizer and Kite Pharma by using AI to design proteins that mount a multi-pronged attack on diseases. Read More
Researchers from Nobel Laureate David Baker’s lab at the University of Washington have successfully used AI to design antibodies from scratch. Read More
Philips Ultrasound is laying off 33 employees from its Bothell, Wash., facility, which serves as a hub for the manufacturing of ultrasound and other healthcare devices. Read More
Inventprise, a Redmond, Wash.–based biotechnology company developing vaccines for infectious diseases, is laying off 76 workers, according to a new… Read More
Brook.ai, a Seattle-based health technology startup that uses AI to help clinical teams to deliver remote care, announced a $28 million Series B round led by UMass Memorial Health and Morningside. Read More
Seattle biotech companies are using AI to design new medical treatments, but scientists caution the tech holds enormous promise, but needs to stay grounded in reality. Read More
The virus-fighting startup Singletto has U.S. Department of Defense support, closed a $10 million round, and is selling its pathogen-killing face masks on Amazon. Read More
Seattle-based biotech startup Lumen Bioscience raised a $30 million Series C extension and announced several leadership updates. WestRiver Group led… Read More
The groundbreaking immunology research behind two Nobel Prizes awarded this week traces back to a largely forgotten biotech startup backed by Bill Gates and Paul Allen. Read More
Mary Brunkow of the Seattle-based Institute for Systems Biology, Fred Ramsdell of Sonoma Biotherapeutics, and David Baker of the UW’s Institute for Protein Design were honored for their research. Read More
Seattle scientist Mary Brunkow of the Institute for Systems Biology (ISB) won a Nobel Prize for research on the immune cells that prevent our body from attacking itself. Read More
Alpyne Labs created its AI-powered tool to take care of benefits checks, billing, scheduling, notes organization and more to free up therapists to concentrate on patient care. Read More
A consortium of top U.S. cancer centers has developed an AI platform that trains models on clinical data from multiple institutions while protecting patient privacy, with the goal of cutting the timeline for new discoveries in cancer research from years to months. Read More
As new startups and initiatives continue to bolster its standing, Seattle is being called “the best place in the world to build an AI life sciences company.” Read More
The Seattle-based biotech company aims to make new drug discovery faster and cheaper by using AI to simulate the results from hypothetical lab tests. Read More
LumiThera’s key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on patients with dry age-related macular degeneration. Read More
Once a scrappy startup lab, Fred Hutchinson Cancer Center is now a global leader in cancer research. As it turns 50, the Seattle institution faces federal funding cuts that could slow progress. Read More
AI will transform healthcare in the next 1-2 years by connecting directly to personal medical records to give patients new levels of health insights, current and former Microsoft execs predicted Tuesday. Read More
Lila Biologics hopes to hand off a candidate protein within three to six months so the pharmaceutical giant can take the drug through clinical trials. Read More
